399 related articles for article (PubMed ID: 29179872)
1. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.
Dochez C; Burnett RJ; Mbassi SM; Were F; Musyoki A; Trovoada D; Mphahlele MJ
Papillomavirus Res; 2017 Dec; 4():66-71. PubMed ID: 29179872
[TBL] [Abstract][Full Text] [Related]
2. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
[TBL] [Abstract][Full Text] [Related]
3. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?
Amponsah-Dacosta E; Blose N; Nkwinika VV; Chepkurui V
Front Public Health; 2022; 10():799984. PubMed ID: 35174123
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania.
Watson-Jones D; Lees S; Mwanga J; Neke N; Changalucha J; Broutet N; Maduhu I; Kapiga S; Chandra-Mouli V; Bloem P; Ross DA
Health Policy Plan; 2016 Jul; 31(6):691-9. PubMed ID: 26768827
[TBL] [Abstract][Full Text] [Related]
7. A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.
Hutubessy R; Levin A; Wang S; Morgan W; Ally M; John T; Broutet N
BMC Med; 2012 Nov; 10():136. PubMed ID: 23146319
[TBL] [Abstract][Full Text] [Related]
8. HPV vaccine introduction in Rwanda: Impacts on the broader health system.
Torres-Rueda S; Rulisa S; Burchett HE; Mivumbi NV; Mounier-Jack S
Sex Reprod Healthc; 2016 Mar; 7():46-51. PubMed ID: 26826045
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013.
Raesima MM; Forhan SE; Voetsch AC; Hewitt S; Hariri S; Wang SA; Pelletier AR; Letebele M; Pheto T; Ramogola-Masire D; El-Halabi S
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(40):1147-9. PubMed ID: 26468997
[TBL] [Abstract][Full Text] [Related]
10. National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.
Mphuru A; Li AJ; Kyesi F; Mwengee W; Mazige F; Nshunju R; Shayo B; Giattas MR; Loharikar A; Lyimo D
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A2-A9. PubMed ID: 33962839
[TBL] [Abstract][Full Text] [Related]
11. Adolescent Health Series: HPV infection and vaccination in sub-Saharan Africa: 10 years of research in Tanzanian female adolescents - narrative review.
Whitworth H; Changalucha J; Baisley K; Watson-Jones D
Trop Med Int Health; 2021 Nov; 26(11):1345-1355. PubMed ID: 34310816
[TBL] [Abstract][Full Text] [Related]
12. Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
Li AJ; Manzi F; Kyesi F; Makame Y; Mwengee W; Fleming M; Mkopi A; Mmbaga S; Lyimo D; Loharikar A
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A38-A48. PubMed ID: 34229889
[TBL] [Abstract][Full Text] [Related]
13. Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania.
Quentin W; Terris-Prestholt F; Changalucha J; Soteli S; Edmunds WJ; Hutubessy R; Ross DA; Kapiga S; Hayes R; Watson-Jones D
BMC Med; 2012 Nov; 10():137. PubMed ID: 23148516
[TBL] [Abstract][Full Text] [Related]
14. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
15. The impact of a human papillomavirus (HPV) vaccination campaign on routine primary health service provision and health workers in Tanzania: a controlled before and after study.
Gallagher KE; Erio T; Baisley K; Lees S; Watson-Jones D
BMC Health Serv Res; 2018 Mar; 18(1):173. PubMed ID: 29530042
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda.
Mugisha E; LaMontagne DS; Katahoire AR; Murokora D; Kumakech E; Seruyange R; Tsu VD
Afr Health Sci; 2015 Mar; 15(1):33-41. PubMed ID: 25834528
[TBL] [Abstract][Full Text] [Related]
17. National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned.
Casey RM; Adrien N; Badiane O; Diallo A; Loko Roka J; Brennan T; Doshi R; Garon J; Loharikar A
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A10-A16. PubMed ID: 34593269
[TBL] [Abstract][Full Text] [Related]
18. Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts.
Sankaranarayanan R; Basu P; Kaur P; Bhaskar R; Singh GB; Denzongpa P; Grover RK; Sebastian P; Saikia T; Oswal K; Kanodia R; Dsouza A; Mehrotra R; Rath GK; Jaggi V; Kashyap S; Kataria I; Hariprasad R; Sasieni P; Bhatla N; Rajaraman P; Trimble EL; Swaminathan S; Purushotham A
Lancet Oncol; 2019 Nov; 20(11):e637-e644. PubMed ID: 31674322
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia.
Simuyemba MC; Chama-Chiliba CM; Chompolola A; Sinyangwe A; Bchir A; Asiimwe G; Chibwesha C; Masiye F
BMC Infect Dis; 2024 Apr; 24(1):369. PubMed ID: 38565994
[TBL] [Abstract][Full Text] [Related]
20. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program.
Paul P; Fabio A
Vaccine; 2014 Jan; 32(3):320-6. PubMed ID: 24295804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
